Key Takeaways
- Methylene blue is promoted online as a cancer treatment, lacking scientific evidence.
- The substance has legitimate medical uses, including treating methemoglobinemia and cyanide poisoning.
- Historically, women scientists, such as Dr. Matilda Brooks, faced discrimination and lack of attribution for their work.
- Unproven wellness trends for methylene blue are fueled by visible effects and unsubstantiated claims.
- Consumers risk harm by sourcing prescription methylene blue from unregulated channels like fish tank supplies.
Deep Dive
- Dr. Sydnee McElroy encountered methylene blue promoted as a cancer treatment online at 2:39.
- A medical student, Priya, also inquired about methylene blue as a wellness trend, indicating its recurrence at 4:09.
- The substance is currently being touted for various unproven health benefits, including cancer treatment.
- Methylene blue was synthesized in 1876 by Heinrich Caro, initially as a textile dye.
- By 1891, early research suggested its use as an antimalarial treatment.
- Studies in 1932 compared it to quinine for malaria, finding it non-inferior but not superior.
- A noticeable side effect was turning bodily fluids, like urine and whites of eyes, blue.
- Cellular biologist Dr. Matilda Brooks discovered further uses for methylene blue in 1932 at UC Berkeley.
- She faced gender-based discrimination, working as an unpaid research assistant due to an anti-nepotism policy.
- After her husband's death, she received only a $500 annual stipend and had to self-fund her research and travel.
- Methylene blue functions as a redox dye, changing color based on its oxidation state, making it useful in lab experiments.
- It can act as a cyanide antidote by bypassing the blockage of ATP production in mitochondria.
- Dr. Brooks presented findings on methylene blue as a cyanide antidote in 1932, which were later published without full credit.
- Dr. Brooks' 1932 findings on methylene blue as a cyanide antidote were published in a JAMA article by Dr. J.C. Geiger without proper attribution.
- The episode highlights a historical pattern of women's scientific contributions being overlooked or appropriated.
- Hosts revisited an academic exchange involving a letter to the editor in JAMA and an author's response regarding a discovery dispute.
- Methylene blue legitimately treats methemoglobinemia, a condition where hemoglobin's oxygen transport is impaired.
- It is also a potential treatment for cyanide poisoning and an adjunct therapy for malaria, with recent resurgence in interest.
- Risks include interactions with antidepressants, potentially causing serotonin syndrome, and inducing methemoglobinemia if incorrectly administered.
- Wellness influencers, including Ben Greenfield, promoted methylene blue as a cognitive enhancer, showcasing a visible blue tongue.
- Consumers are sourcing prescription methylene blue from unregulated channels, such as fish tank cleaning supplies.
- The visible blue tongue effect fosters an illusion of efficacy for unproven anti-aging, energy, and stamina claims.
- Charlatans exploit desperation by selling unproven treatments, a practice legitimate medical science avoids with safeguards.